AGP Picks
View all

South Carolina Sci-Tech Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on South Carolina Sci-Tech Wire.

Press releases published on October 22, 2026

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer
WEL Companies Streamlines Freight Brokerage and Carrier Workflows with Integrated Descartes and CARRIER1 Solutions
NewsGenie Demonstrates the Future of Journalism with BalVoi, a 100% AI-Automated Newsroom
Istios Health Expands Clinical Research Network into Texas Through Kidney Care Associates Partnership
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection
EC-Council Expands Technology Risk Capabilities Through Acquisition of Cyber Insurance Academy
Virtune announces harmonization of rebalancing schedules for selected index ETPs
Virtune meddelar harmonisering av rebalanseringsschemat för utvalda index-ETP:er
iGarden Robotic Pool Cleaners K Series: A Smart Choice for US Pool Owners
Levicept Announces Attendance at Major Healthcare Conferences in Q4
BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management Solutions
A Breakthrough in Hanmi Life Sciences, GeneAKG® Sets a New Global Benchmark in Anti-Aging with Proprietary Patented Technology
Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy
Regula Contributes Expertise to New Analyst Research on Know-Your-Business Requirements
Arrakis Security Report Finds 76% of AI Agents Are Dormant but Keep Their Credentials and Connections
Persica Pharmaceuticals presents antibiotic exposure-response analysis at the International Society of Pain & Neuroscience (ISPN) Annual Conference
Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis
Ipsen réalise une croissance remarquable des ventes au cours des neuf premiers mois de 2026 et relève à nouveau ses prévisions pour l’exercice en cours

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

South Carolina Sci-Tech Wire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.